title: Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients.
abstract: OBJECTIVE
  To compare the efficacy of two atypical antipsychotic drugs, olanzapine and risperidone, in schizophrenic patients with post-psychotic depression.
  
  
  RESULTS
  A clinically significant decrease of MADRS scores occurred in patients treated with both drugs for 8 weeks.
  
  
  CONCLUSIONS
  Atypical antipsychotic drugs may be particularly appropriate when treating schizophrenic patients with depression.
authors.affiliation: Department of psychiatry, Centre Esquirol, Centre Hospitalier et Universitaire, avenue de la Côte de Nacre, Caen, 14000, France. dollfus-s@chu-caen.fr
authors.forename: Sonia
authors.initials: S
authors.lastname: Dollfus
authors.forename: Véronique
authors.initials: V
authors.lastname: Olivier
authors.forename: Benoît
authors.initials: B
authors.lastname: Chabot
authors.forename: Cécile
authors.initials: C
authors.lastname: Déal
authors.forename: Elena
authors.initials: E
authors.lastname: Perrin
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use; D003863:Depression / Q000175:diagnosis* / Q000209:etiology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D011618:Psychotic Disorders / Q000523:psychology*; D018967:Risperidone / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D012720:Severity of Illness Index
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D018967:Risperidone; D000077152:Olanzapine